22157.jpg
Lidocaine Ointment Market Report 2022: Featuring Glenmark Pharmaceuticals, Novocol Pharma, AstraZeneca & More
16 janv. 2023 09h33 HE | Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Lidocaine Ointment Market, by Formulation, by Age Group, by Application, by Distribution Channel, by Region - Size, Share, Outlook, and Opportunity...
22157.jpg
Analgesics Global Market Report 2022: Sector to Reach $56.86 Million by 2030 at a CAGR of 4.9%
10 janv. 2023 05h18 HE | Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Analgesics Market by Type and by Route of Administration - Global Opportunity Analysis and Industry Forecast 2022-2030" report has been added to ...
Logo.jpg
Endonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Company
09 janv. 2023 09h03 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics Inc. (OTCQB: ENDV) today announced details for its plan to spin off its current medical device division, known as NewCo, as a...
ZetrOZ presents at the MLB winter meetings to PBATS
ZetrOZ Systems Hosts Lunch and Lecture for the Professional Baseball Athletic Trainers Society
05 janv. 2023 10h31 HE | ZetrOZ Systems
SAN DIEGO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ZetrOZ Systems hosted a Lunch and Lecture for The Professional Baseball Athletic Trainers Society (PBATS) during the Major League Baseball Winter...
Logo.jpg
Endonovo Announces Advancement of International “Go to Market” Initiative
19 déc. 2022 09h09 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced an aggressive initiative to introduce and develop the sales and benefits of SofPulse®...
Logo.jpg
Endonovo Announces Plans for Spin-off of Medical IP and Assets
15 déc. 2022 09h07 HE | Endonovo Therapeutics, Inc.
New Company To Be Formed for SofPulse® Medical Device Line Los Angeles, CA, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced plans to affect a...
sam®x1 treating lower back injuries to reduce recovery time
Innovative Soft Tissue Healing Treatments Now Available for Chronic Pain Sufferers in Virginia and Mid-Atlantic Region
14 déc. 2022 11h31 HE | ZetrOZ Systems
VIRGINIA BEACH, Va., Dec. 14, 2022 (GLOBE NEWSWIRE) -- ZetrOZ Systems announces that the sam®x1, the only wireless ultrasound device with FDA clearance for at-home use, has been launched and is...
Logo.jpg
Endonovo Launches Telehealth Initiative
13 déc. 2022 09h11 HE | Endonovo Therapeutics, Inc.
Expands Patient Education, Access to Non-Opioid Options for Pain Management Los Angeles, CA, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the...
PhysicianLogo.jpg
Physician Growth Partners advises Wellspring Pain Solutions in transaction with Capitol Pain Institute and Iron Path Capital
12 déc. 2022 17h09 HE | Physician Growth Partners
CHICAGO, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Physician Growth Partners (“PGP”) is pleased to have represented Bloomington, IN-based Wellspring Pain Solutions (“Wellspring”) in its transaction with...
sam® home use treatment for knee pain
Long-Duration Ultrasound Treatment With sam® Elevates Regenerative Medicine Options for Patients
12 déc. 2022 12h16 HE | ZetrOZ Systems
ATLANTA, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Sustained Acoustic Medicine (sam®) technology, the FDA-cleared ultrasound device created by ZetrOZ Systems, continues to demonstrate its ability to relieve...